R E Heikkila - JoVE Visualize

Showing results (81-90 of 87) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 87 results.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1976

Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanolG Cohen, R E Heikkila, B Allis, et al.

Journal of Neurochemistry|December 1, 1989

Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation productsS K Youngster, K A McKeown, Y Z Jin, et al.

Neurology|August 1, 1994

Meige syndrome in the spectrum of Lewy body diseaseM H Mark, J I Sage, D W Dickson, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988

Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineR E Heikkila, M V Kindt, P K Sonsalla, et al.

Brain Research|July 10, 1989

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studiesK F Manaye, P K Sonsalla, G Barnett, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989

Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP+) analogs and their energized accumulation by mitochondriaR R Ramsay, S K Youngster, W J Nicklas, et al.

Clinical Neuropharmacology|June 1, 1988

Isolated jejunal pouches for levodopa delivery in parkinsonian patients with "on-off". Successful experimental model in dogsJ I Sage, S Trooskin, L Schuh, et al.

Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 87 results.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1976

Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanolG Cohen, R E Heikkila, B Allis, et al.

Journal of Neurochemistry|December 1, 1989

Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation productsS K Youngster, K A McKeown, Y Z Jin, et al.

Neurology|August 1, 1994

Meige syndrome in the spectrum of Lewy body diseaseM H Mark, J I Sage, D W Dickson, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988

Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineR E Heikkila, M V Kindt, P K Sonsalla, et al.

Brain Research|July 10, 1989

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studiesK F Manaye, P K Sonsalla, G Barnett, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989

Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP+) analogs and their energized accumulation by mitochondriaR R Ramsay, S K Youngster, W J Nicklas, et al.

Clinical Neuropharmacology|June 1, 1988

Isolated jejunal pouches for levodopa delivery in parkinsonian patients with "on-off". Successful experimental model in dogsJ I Sage, S Trooskin, L Schuh, et al.

Pageof 9